Effect of Electroacupuncture in Patients With Sepsis Associated Brain Injury
Not Applicable
- Conditions
- SepsisElectroacupunctureSepsis-associated Brain Injury
- Interventions
- Other: shame electroacupunctureOther: electroacupuncture
- Registration Number
- NCT05171699
- Lead Sponsor
- Tianjin Nankai Hospital
- Brief Summary
To investigate the effect of electroacupuncture on patients with sepsis-associated brain injury.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Age is between 20 and 80 years.
- Patients meeting the diagnosis of sepsis-associated brain injury.
- Patients who agreed to accept this trial and signed the informed consent form.
Exclusion Criteria
- Patients with a history of brain injury, stroke, epilepsy, cognitive impairment, or mental illness prior to admission.
- Patients who were also involved in any other interventional study.
- Due to hearing or vision loss, or any other situation that may seriously interfere with study data collection.
- Patients who refused to participate in this study.
- The pregnancy test was positive or is currently breastfeeding.
- Any other situation that the investigator believed might be detrimental to participant in the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description shame electroacupuncture shame electroacupuncture The shame electroacupuncture were performed at a shallow depth and 1 mm lateral to Zusanli (ST36) and Baihui (DU20) acupoints. electroacupuncture electroacupuncture The investigators choose Zusanli (ST36) and Baihui (DU20) acupoints to investigate the effect of electroacupuncture on patients with sepsis-associated brain injury.
- Primary Outcome Measures
Name Time Method neuron specific enolase,NSE Change of NSE from Baseline at 7 days Serum index of sepsis-associated brain injury.
sTREM2 Change of sTREM2 from Baseline at 7 days Serum index of sepsis-associated brain injury.
soluble protein-100β,S100β Change of S100β from Baseline at 7 days Serum index of sepsis-associated brain injury.
- Secondary Outcome Measures
Name Time Method Montreal Cognitive Assessment (MoCA) scale Change of MoCA from Baseline at 7 days Rapid screening for cognitive function abnormalities。
Acute Physiology and Chronic Health Evaluation,APACHE II Change of APACHE II from Baseline at 7 days To assess the severity of the disease.
Glasgow Coma Scale,GCS Change of GCS from Baseline at 7 days To assess the degree of coma.
Trial Locations
- Locations (1)
Tianjin Nankai Hospital
🇨🇳Tianjin, Tianjin, China